Skadden, MoFo Help Secure $4B OSI, Astellas Deal
Ending a two-month battle over the purchase price, Japan-based Astellas Pharma Inc. has secured ownership of OSI Pharmaceuticals Inc. by upping its offer to about $4 billion....To view the full article, register now.
Already a subscriber? Click here to view full article